![Robert Cuthbertson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Cuthbertson
Direktör/Styrelseledamot på
ZENYTH THERAPEUTICS LIMITED
Förmögenhet: 6 M $ per 2026-07-31
Profil
Robert Andrew Cuthbertson is currently Director at CSL Innovation Pty Ltd., Non-independent Executive Director at CSL Behring LLC since 2018, Director at Centre for Eye Research Australia since 2017, Director at Grattan Institute since 2019, Non-Executive Director at CSL Ltd. since 2021, and Deputy Chancellor at the University of Melbourne since 2023.
Formerly, Dr. Cuthbertson was Senior Scientist at Genentech, Inc. from 1992 to 1997, and a Member at both the National Institutes of Health and the Howard Florey Institute.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
CSL LIMITED 0,01 % | 2026-02-17 | 71 128 ( 0,01 % ) | 6 M $ | 2026-07-31 |
Aktiva positioner av Robert Cuthbertson
| Företag | Position | Start |
|---|---|---|
| ZENYTH THERAPEUTICS LIMITED | Direktör/Styrelseledamot | - |
| CSL LIMITED | Direktör/Styrelseledamot | 2018-10-17 |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Direktör/Styrelseledamot | 2018-01-01 |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | 2016-01-01 |
Centre for Eye Research Australia
 Centre for Eye Research Australia General GovernmentGovernment Eliminates vision loss and blindness | Direktör/Styrelseledamot | 2017-03-01 |
Grattan Institute
 Grattan Institute Miscellaneous Commercial ServicesCommercial Services Develops public policy programs | Direktör/Styrelseledamot | 2019-01-01 |
Tidigare kända positioner av Robert Cuthbertson
| Företag | Position | Slut |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Företagsledare/Principal | 1997-01-01 |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Företagsledare/Principal | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
67
Första gradens relationer
8
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
CSL Innovation Pty Ltd.
 CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
Centre for Eye Research Australia
Centre for Eye Research Australia General GovernmentGovernment Eliminates vision loss and blindness | Government |
Grattan Institute
Grattan Institute Miscellaneous Commercial ServicesCommercial Services Develops public policy programs | Commercial Services |
